PRINCIPAL INVESTIGATOR(s)
SPONSORS
AMOUNT AWARDED
PROJECT PERIOD
       
Michael Smith NIH (K08) $810,000 12/01/2023 - 11/30/2028
Title: Centralized Pain Management In Older Adult Cancer Survivors
       
Vicki Ellingrod (MPI) NIH (R25) $540,000 12/01/2023 - 11/30/2028
Title: Michigan Institute for Clinical and Health Research (MICHR) - R25
       
Vicki Ellingrod (MPI) NIH (T32) $2,706,600.00 12/01/2023 - 11/30/2028
Title: Michigan Institute for Clinical and Health Research (MICHR) - Postdoctoral T32
       
Amanda Garner Prism BioLab Co. $17,169 12/1/2023 - 01/31/2024
Title: Prism BioLab eIF4E & eIF4G Testing
       
Guizhi Zhu Rogel Cancer Center Discovery Award $75,000 11/01/2023 - 10/31/2024
Title: Develop Small CircRNA Vaccines for Combination Immunotherapy of Melanoma
       
Peter Tessier (MPI) UM - Israel Partnership for Research and Education $50,000 10/01/2023 - 09/30/2033
Title: Computational Rehumanization of Therapeutic Antibodies for Reducing Self-Association
       
Peter Tessier Genentech $356,838 10/01/2023 - 10/31/2025
Title: Ultra-Dilute Measurements of Antibody Self-Association for Identifying Antibody Variants and Formulations with Favorable High Concentration Solution Properties
       
Peter Tessier Incyte $145,542 10/01/2023 - 09/30/2024
Title: Therapeutic Antibody Experimental and Computational Developability Analysis
       
Steven Schwendeman (MPI) UM - Israel Partnership for Research and Education $50,000 10/01/2023 - 09/30/2024
Title: A Novel Strategy to Decrease Alpha-Synuclein Pathology in Parkinson’s Disease
       
James Moon (MPI) UM - Frankel Innovation Initiative $496,958 10/01/2023 - 09/30/2024
Title: New Nanoparticle Platform for Metallo-Immunotherapy
       
Peter Tessier DoD $3,695,141.00 09/01/2023 - 09/30/2026
Title: CD98hc-Mediated Delivery of an Ultrapotent TrkB Agonist Antibody for Neuroprotection and Improved Cognitive Recovery After Traumatic Brain Injury
       
Timothy Cernak Alfred P. Sloan Foundation $75,000 09/01/2023 - 09/30/2025
Title: Cernak- Sloan Research Fellowship 2023
       
Amna Rizvi-Toner (Karen Farris) AFPE $20,000.00 09/01/2023 - 08/31/2024
Title: Oral Anticancer Agents: Symptom Self- Management and Healthcare Utilization
       
Steven Schwendeman Merck Sharp & Dohme LLC $5,000 09/01/2023 - 08/31/2024
Title: Pharmaceutical Sciences Seminar Program (2023-2024)
       
Dalia Soueid (Amanda Garner) ACS $35,000 09/01/2023 - 08/31/2024
Title: Cell-Based Assay Development Strategies to Probe Dysregulated mRNA-Protein Interactions for Drug Discovery
       
Garner, Amanda             Ono Pharma Foundation $1,035,000 08/1/2023 - 07/31/2026
Title: Chemical Manipulation of RNA-Protein Interactions for RNA-Targeted Drug Discovery
       
James Moon (MPI) NIH (R01) $2,771,422 07/01/2023 - 06/30/2028
Title: Restoring the Immunogenicity of Head and Neck Cancer
       
Anna Schwendeman (MPI) NIH (R01) $3,055,740 07/01/2023 - 05/31/2027
Title: Development of Phospholipid-Based Nanotherapeutics for Treating Abdominal Aortic Aneurysm
 

 

PRINCIPAL INVESTIGATOR(s)

SPONSORS

AMOUNT AWARDED

PROJECT PERIOD

       
Amit Pai  MICHR Clinical & Translational Science Pilot Award $50,000 03/01/2024 - 02/28/2025
Title: Advancing Precision Medicine: A Microdose Approach for Universal Kidney Function Measurement
       
Guizhi Zhu College of Pharmacy - Research Stimulus Award $50,000 03/01/2024 - 02/28/2025
Title: Pulmonary Delivery of Circular RNA (circRNA) Therapeutics for Cystic Fibrosis
       
Michael Dorsch Department of Veteran Affairs $2,000 03/01/2024 - 02/28/2025
Title: IPA Agreement
       
Peter Toogood (MPI) College of Pharmacy - William & Sally Searle Cancer Research Award $50,000 03/01/2024 - 02/28/2025
Title: Optimization of Malic Enzyme 1 Inhibitors for the Treatment of Pancreatic Cancer
       
Wei Cheng Tulane University $75,000 03/01/2024 - 02/28/2025
Title: Synthetic virus-like structures as a new platform for vaccines and understanding B cell biology
       
Wei Gao and Duxin Sun NIH (R01) $2,645,385 02/01/2024 - 01/31/2029
Title: Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy
       
Steven Erickson Center for Research in Learning & Teaching $1,000 01/01/2024 - 04/30/2024
Title: Health and Disabilities P517 Course: Interprofessional Client Experiences
       
Karen Farris Rho Chi Society $679,628 01/01/2024 - 12/31/2028
Title: Rho Chi Society National Office Leadership
       
Minzhi Yu (Schwendeman Anna) American Heart Association $144,580 01/01/2024 - 12/31/2025
Title: Development of Nitro-fatty-acid Loaded Synthetic High-density Lipoproteins for Abdominal Arterial Aneurysm Treatment

 

2023

 

PRINCIPAL INVESTIGATOR(s)
SPONSORS
AMOUNT AWARDED
PROJECT PERIOD
       
Michael Smith NIH (K08) $810,000 12/01/2023 - 11/30/2028
Title: Centralized Pain Management In Older Adult Cancer Survivors
       
Vicki Ellingrod (MPI) NIH (R25) $540,000 12/01/2023 - 11/30/2028
Title: Michigan Institute for Clinical and Health Research (MICHR) - R25
       
Vicki Ellingrod (MPI) NIH (T32) $2,706,600.00 12/01/2023 - 11/30/2028
Title: Michigan Institute for Clinical and Health Research (MICHR) - Postdoctoral T32
       
Amanda Garner Prism BioLab Co. $17,169 12/1/2023 - 01/31/2024
Title: Prism BioLab eIF4E & eIF4G Testing
       
Guizhi Zhu Rogel Cancer Center Discovery Award $75,000 11/01/2023 - 10/31/2024
Title: Develop Small CircRNA Vaccines for Combination Immunotherapy of Melanoma
       
Peter Tessier (MPI) UM - Israel Partnership for Research and Education $50,000 10/01/2023 - 09/30/2033
Title: Computational Rehumanization of Therapeutic Antibodies for Reducing Self-Association
       
Peter Tessier Genentech $356,838 10/01/2023 - 10/31/2025
Title: Ultra-Dilute Measurements of Antibody Self-Association for Identifying Antibody Variants and Formulations with Favorable High Concentration Solution Properties
       
Peter Tessier Incyte $145,542 10/01/2023 - 09/30/2024
Title: Therapeutic Antibody Experimental and Computational Developability Analysis
       
Steven Schwendeman (MPI) UM - Israel Partnership for Research and Education $50,000 10/01/2023 - 09/30/2024
Title: A Novel Strategy to Decrease Alpha-Synuclein Pathology in Parkinson’s Disease
       
James Moon (MPI) UM - Frankel Innovation Initiative $496,958 10/01/2023 - 09/30/2024
Title: New Nanoparticle Platform for Metallo-Immunotherapy
       
Peter Tessier DoD $3,695,141.00 09/01/2023 - 09/30/2026
Title: CD98hc-Mediated Delivery of an Ultrapotent TrkB Agonist Antibody for Neuroprotection and Improved Cognitive Recovery After Traumatic Brain Injury
       
Timothy Cernak Alfred P. Sloan Foundation $75,000 09/01/2023 - 09/30/2025
Title: Cernak- Sloan Research Fellowship 2023
       
Amna Rizvi-Toner (Karen Farris) AFPE $20,000.00 09/01/2023 - 08/31/2024
Title: Oral Anticancer Agents: Symptom Self- Management and Healthcare Utilization
       
Steven Schwendeman Merck Sharp & Dohme LLC $5,000 09/01/2023 - 08/31/2024
Title: Pharmaceutical Sciences Seminar Program (2023-2024)
       
Dalia Soueid (Amanda Garner) ACS $35,000 09/01/2023 - 08/31/2024
Title: Cell-Based Assay Development Strategies to Probe Dysregulated mRNA-Protein Interactions for Drug Discovery
       
Garner, Amanda             Ono Pharma Foundation $1,035,000 08/1/2023 - 07/31/2026
Title: Chemical Manipulation of RNA-Protein Interactions for RNA-Targeted Drug Discovery
       
James Moon (MPI) NIH (R01) $2,771,422 07/01/2023 - 06/30/2028
Title: Restoring the Immunogenicity of Head and Neck Cancer
       
Anna Schwendeman (MPI) NIH (R01) $3,055,740 07/01/2023 - 05/31/2027
Title: Development of Phospholipid-Based Nanotherapeutics for Treating Abdominal Aortic Aneurysm
 

 

2024

PRINCIPAL INVESTIGATOR(s)

SPONSORS

AMOUNT AWARDED

PROJECT PERIOD

       
Amit Pai  MICHR Clinical & Translational Science Pilot Award $50,000 03/01/2024 - 02/28/2025
Title: Advancing Precision Medicine: A Microdose Approach for Universal Kidney Function Measurement
       
Guizhi Zhu College of Pharmacy - Research Stimulus Award $50,000 03/01/2024 - 02/28/2025
Title: Pulmonary Delivery of Circular RNA (circRNA) Therapeutics for Cystic Fibrosis
       
Michael Dorsch Department of Veteran Affairs $2,000 03/01/2024 - 02/28/2025
Title: IPA Agreement
       
Peter Toogood (MPI) College of Pharmacy - William & Sally Searle Cancer Research Award $50,000 03/01/2024 - 02/28/2025
Title: Optimization of Malic Enzyme 1 Inhibitors for the Treatment of Pancreatic Cancer
       
Wei Cheng Tulane University $75,000 03/01/2024 - 02/28/2025
Title: Synthetic virus-like structures as a new platform for vaccines and understanding B cell biology
       
Wei Gao and Duxin Sun NIH (R01) $2,645,385 02/01/2024 - 01/31/2029
Title: Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy
       
Steven Erickson Center for Research in Learning & Teaching $1,000 01/01/2024 - 04/30/2024
Title: Health and Disabilities P517 Course: Interprofessional Client Experiences
       
Karen Farris Rho Chi Society $679,628 01/01/2024 - 12/31/2028
Title: Rho Chi Society National Office Leadership
       
Minzhi Yu (Schwendeman Anna) American Heart Association $144,580 01/01/2024 - 12/31/2025
Title: Development of Nitro-fatty-acid Loaded Synthetic High-density Lipoproteins for Abdominal Arterial Aneurysm Treatment

 

Listing Row

Wednesday, March 13, 2024
Wednesday, March 13, 2024